Josef Gramespacher, PhDCo-founder and Senior Scientist at EpiBiologicsSpeaker
Profile
Josef Gramespacher is a co-founder and current senior scientist at EpiBiologics, a company focused on developing first-in-class antibody-based therapies to degrade disease driving membrane and extracellular proteins. Prior to joining EpiBiologics, Josef was a postdoctoral fellow at UCSF working under the supervision of Jim Wells.
Agenda Sessions
Harnessing Modular E3 Ligase and Cytokine Receptor Targeting Chimeras to Degrade Cell-surface and Extracellular Proteins
, 11:00amView Session